The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...

A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...

Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.

Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...

Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in combination with immunotherapy for adult patients ...

“It gives me the ick when influencers share weight loss advice” says Yorkshire pharmacist Nadia Malik.

With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...

The Food and Drug Administration (FDA) has approved Zycubo® (copper histidinate) for the treatment of Menkes disease in pediatric patients.

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...

Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.

The collaboration between ten23 health and BD aims to commercialize the BD Libertas wearable injector for large-volume ...